ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-4877ometendo-4877Research ArticleСтатьиArticlesКомплексный подход к лечению ожиренияи метаболического синдрома у мужчинKompleksnyy podkhod k lecheniyu ozhireniyai metabolicheskogo sindroma u muzhchinRozhivanovR Ve-mail: rrozhivanov@mail.ruShurdumovaB O-ParfenovaN Sdrnot@mail.ruSavel'evaL V-20091512200964№4 (2009)3841Copyright © Rozhivanov R.V., Shurdumova B.O., Parfenova N.S., Savel'eva L.V., 20092009Rozhivanov R.V., Shurdumova B.O., Parfenova N.S., Savel'eva L.V.Rozhivanov R.V., Shurdumova B.O., Parfenova N.S., Savel'eva L.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/4877

У мужчин развивается абдоминальное ожирение, которое сопровождается высоким риском развития сопутствующих заболеваний. В статье приводятся данные разных авторов о тесной связи между ожирением и метаболическим синдромом с гипогонадизмом у мужчин. Снижение массы тела на фоне лечения Ксеникалом сопровождается улучшением симптомов метаболического синдрома.

There is abdominal obesity in men that is accompanied with high risk of concomitant disease. The different authors data about close relation between obesity and metabolic syndrome with hypogonadism in men are performed in this article. Reduction of body weight due to the treatment with Xenical is accompanied by improvement of metabolic syndrome symptoms.

абдоминальное ожирениеметаболический синдромКсеникалabdominal obesitymetabolic syndromeXenicalReferencesАндрология. Мужское здоровье и дисфункция репродуктивной системы // Под ред. Э. Нишлага, Г.М. Бере. М.; 2005; 554 с.Андрология. Мужское здоровье и дисфункция репродуктивной системы // Под ред. Э. Нишлага, Г.М. Бере. М.; 2005; 554 с.Бутрова С.А. Лечение ожирения // Материалы 1-го Московского съезда эн- докринологов: Современные концепции клинической эндокринологии. М.; 1997; 172-77.Бутрова С.А. Лечение ожирения // Материалы 1-го Московского съезда эн- докринологов: Современные концепции клинической эндокринологии. М.; 1997; 172-77.Григорьев П.Я., Исаков В.А., Яковенко Э.П. Патогенетические основы али- ментарного ожирения // Тер. архив. 1989; 61(9): 120-25.Григорьев П.Я., Исаков В.А., Яковенко Э.П. Патогенетические основы али- ментарного ожирения // Тер. архив. 1989; 61(9): 120-25.Ивлева А.Я., Старостина Е.Г. Ожирение - проблема медицинская, а не кос- метическая // М.; 2002; 22.Ивлева А.Я., Старостина Е.Г. Ожирение - проблема медицинская, а не кос- метическая // М.; 2002; 22.Калинченко С.Ю., Роживанов Р.В. Особенности лечения ожирения у муж- чин // Ожирение и метаболизм, 2005.Калинченко С.Ю., Роживанов Р.В. Особенности лечения ожирения у муж- чин // Ожирение и метаболизм, 2005.Татонь Я. Ожирение: патофизиология, диагностика, лечение // М.: Медицина, 1981; 363 с.Татонь Я. Ожирение: патофизиология, диагностика, лечение // М.: Медицина, 1981; 363 с.Угланова Т.М. Патогенез, классификация и терапия ожирения // Сб. науч. труд.: Патология метаболизма: атеросклероз, ожирение, сахарный диабет. - Нижний Новгород, 1992; 83-91.Угланова Т.М. Патогенез, классификация и терапия ожирения // Сб. науч. труд.: Патология метаболизма: атеросклероз, ожирение, сахарный диабет. - Нижний Новгород, 1992; 83-91.American Diabetes Association. Management of Dyslipidemia in Adults With Diabetes. Position Statement // J. Diabetes. Care. 1999; 22: 9-56.American Diabetes Association. Management of Dyslipidemia in Adults With Diabetes. Position Statement // J. Diabetes. Care. 1999; 22: 9-56.Anderson К.A., Costelli W.R, Levy D. // J. Amer. med. Assoc. 1987; 257: 2176-80.Anderson К.A., Costelli W.R, Levy D. // J. Amer. med. Assoc. 1987; 257: 2176-80.Armellini et al. Hormones and body composition in humans: clinical studies // Int. J. Obes. Relat. Metab. Disord. 2000; 24(2): 18-21.Armellini et al. Hormones and body composition in humans: clinical studies // Int. J. Obes. Relat. Metab. Disord. 2000; 24(2): 18-21.Bjorntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? // J. Intern. Med. 1991; 230: 195-201.Bjorntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? // J. Intern. Med. 1991; 230: 195-201.Cunningham G.R. Management of male aging: which testosterone replacement therapy should be used? // The Aging Male. 2000; 3: 203-9.Cunningham G.R. Management of male aging: which testosterone replacement therapy should be used? // The Aging Male. 2000; 3: 203-9.Dobs et al. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation- enhanced testosterone transdermal system // J. Clin. Endocrinol. Metab. 2001; 86(3): 1026-33.Dobs et al. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation- enhanced testosterone transdermal system // J. Clin. Endocrinol. Metab. 2001; 86(3): 1026-33.Grundy S.M. Multifactorial causation of obesity: implications for prevention // Am. J. Clin. Nutr. 1998; 67(1): 563S-572S.Grundy S.M. Multifactorial causation of obesity: implications for prevention // Am. J. Clin. Nutr. 1998; 67(1): 563S-572S.Hak et al. Тhe Rotterdam study, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study // J. Clin. Endocrinol. Metab. 2002; 87(8): 3632-9.Hak et al. Тhe Rotterdam study, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study // J. Clin. Endocrinol. Metab. 2002; 87(8): 3632-9.Haffner S.M., Miettinen H., Mykkanen L., Stern M.P. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/ insulin ratio in non-diabetic subjects // Int. J. Obes. Relat. Metab. Disord. 1998; 22(9): 899-905.Haffner S.M., Miettinen H., Mykkanen L., Stern M.P. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/ insulin ratio in non-diabetic subjects // Int. J. Obes. Relat. Metab. Disord. 1998; 22(9): 899-905.Hennes S., Perry C.M. Orlistat. Drugs 2006; 66(12): 1625-56.Hennes S., Perry C.M. Orlistat. Drugs 2006; 66(12): 1625-56.Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K. DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women // Arch. Intern. Med. 2004; 164(10): 1066-76.Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K. DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women // Arch. Intern. Med. 2004; 164(10): 1066-76.Imoberdorf R. Ballmer P.E. Obesity: principles of drug therapy // Ther. Umsch. 2000; 57 (8): 522-5.Imoberdorf R. Ballmer P.E. Obesity: principles of drug therapy // Ther. Umsch. 2000; 57 (8): 522-5.Isomaa B., Almgren P., Tuomi T., Forsйn B., Lahti K., Nissйn M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome // Diabetes Care. 2001; 24(4): 683-9.Isomaa B., Almgren P., Tuomi T., Forsйn B., Lahti K., Nissйn M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome // Diabetes Care. 2001; 24(4): 683-9.Katznelson et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism // J. Clin. Endocrinol. Metab. 1996; 81(12): 4358-65.Katznelson et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism // J. Clin. Endocrinol. Metab. 1996; 81(12): 4358-65.Kendall D.M., Sobel B.E., Coulston A.M. The insulin resistance syndrome and coronary artery disease // Coron. Artery. Dis. 2003; 14(4): 335-48.Kendall D.M., Sobel B.E., Coulston A.M. The insulin resistance syndrome and coronary artery disease // Coron. Artery. Dis. 2003; 14(4): 335-48.Kissebah A.H., Evans D.J., Peiris A., Wilson C.R. Endocrine characteristics in regional obesities role of sex steroids // Excerpta Medica. - Amsterdam. 1985; 115-30.Kissebah A.H., Evans D.J., Peiris A., Wilson C.R. Endocrine characteristics in regional obesities role of sex steroids // Excerpta Medica. - Amsterdam. 1985; 115-30.Kissebah A.H., Krakower G.R. Regional adiposity and morbidity // Physiol. Rev. 1994; 74: 761-811.Kissebah A.H., Krakower G.R. Regional adiposity and morbidity // Physiol. Rev. 1994; 74: 761-811.Laaksoner D.E., Lokka H.M. et al. // Am. J. Epidemiol. 2002; 156: 1070-7.Laaksoner D.E., Lokka H.M. et al. // Am. J. Epidemiol. 2002; 156: 1070-7.Laaksoner D.E. et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study // Eur. J. Endocrinol. 2003; 149(6): 601-8.Laaksoner D.E. et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study // Eur. J. Endocrinol. 2003; 149(6): 601-8.Leenen R., van der Kooy K., Seidell J.C. et al. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy // J. Clin. Endocrinol. Metab. 1994; 78: 1515-20.Leenen R., van der Kooy K., Seidell J.C. et al. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy // J. Clin. Endocrinol. Metab. 1994; 78: 1515-20.Levine A.S., Giraudo S.Q., Kotz С.М. Billington C.J. Neuropeptides: regulators of energy-, stress- and «reward»-induced feeding // Int. J. of Obes. 2000; 24(l): S6.Levine A.S., Giraudo S.Q., Kotz С.М. Billington C.J. Neuropeptides: regulators of energy-, stress- and «reward»-induced feeding // Int. J. of Obes. 2000; 24(l): S6.Marin P., Holmang S., Jonsson L., Sjostrom L., Kvist H., Holm G., Lindstedt G., Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men // Int. J. Obesity. 1992; 16: 991-7.Marin P., Holmang S., Jonsson L., Sjostrom L., Kvist H., Holm G., Lindstedt G., Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men // Int. J. Obesity. 1992; 16: 991-7.Marin P., Arver S. Androgens and abdominal obesity // Baillieres. Clin. Endocrinol. Metab. 1998; 12(3): 441-51.Marin P., Arver S. Androgens and abdominal obesity // Baillieres. Clin. Endocrinol. Metab. 1998; 12(3): 441-51.Pasquali R., Casimirri F., De Iasio R., Mesini P. et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men // J. Clin. Endocrinol. Metab. 1995; 80: 654-8.Pasquali R., Casimirri F., De Iasio R., Mesini P. et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men // J. Clin. Endocrinol. Metab. 1995; 80: 654-8.Phillips G.B., Pinkernell B.H., Jing T.Y. The association of hypotestosteronemia with coronary artery disease in men // Arterioscler Thromb. 1994; 14(5): 701-6.Phillips G.B., Pinkernell B.H., Jing T.Y. The association of hypotestosteronemia with coronary artery disease in men // Arterioscler Thromb. 1994; 14(5): 701-6.Roncavi D.A.K., Van R.L.R. Promotion of human adipocite precursor replication by 17β-estradiol in culture // J. Clin. Invest. 1977; 62: 503-8.Roncavi D.A.K., Van R.L.R. Promotion of human adipocite precursor replication by 17β-estradiol in culture // J. Clin. Invest. 1977; 62: 503-8.Seidell J.S. The worldwide epidemic of obesity. In: Progress in obesity research. 8th International congress on obesity. Guy-Grand B., Ailhaud G. eds. London. 1999.Seidell J.S. The worldwide epidemic of obesity. In: Progress in obesity research. 8th International congress on obesity. Guy-Grand B., Ailhaud G. eds. London. 1999.Simon et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study // J. Clin. Endocrinol. Metab. 1997; 82(2): 682-5.Simon et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study // J. Clin. Endocrinol. Metab. 1997; 82(2): 682-5.Stellato R.K., Feldman H.A., Hamdy O., Horton E.S., McKinlay J.B. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle- aged men: prospective results from the Massachusetts male aging study // Diabetes Care. 2000; 23(4): 90-494.Stellato R.K., Feldman H.A., Hamdy O., Horton E.S., McKinlay J.B. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle- aged men: prospective results from the Massachusetts male aging study // Diabetes Care. 2000; 23(4): 90-494.Suter P.M., Vetter W. Drug therapy of obesity. Strategies for general practice // Schweiz Rundsch Med Prax. 2000; 89 (14): 575-85.Suter P.M., Vetter W. Drug therapy of obesity. Strategies for general practice // Schweiz Rundsch Med Prax. 2000; 89 (14): 575-85.Svartberg J. et al. Waist circumference and testosterone levels in community dwelling men. The Tromsї study // Europ. J. Epidemiol. 2004; 19(7): 657-63.Svartberg J. et al. Waist circumference and testosterone levels in community dwelling men. The Tromsї study // Europ. J. Epidemiol. 2004; 19(7): 657-63.Tsai E.C., Boyko E.J., Leonetti D.L., Fujimoto W.Y. Low serum testosterone level as predictor of increased visceral fat in Japanese-American men // Int. J. Obes. Relat. Metab. Disord. 2000; 24: 485-91.Tsai E.C., Boyko E.J., Leonetti D.L., Fujimoto W.Y. Low serum testosterone level as predictor of increased visceral fat in Japanese-American men // Int. J. Obes. Relat. Metab. Disord. 2000; 24: 485-91.Wang C. et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men // J. Clin. Endocrinol Metab. 2000; 85(8): 2839-53.Wang C. et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men // J. Clin. Endocrinol Metab. 2000; 85(8): 2839-53.Weiss D. How to help your patients lose weight: current therapy for obesity // Cleve. Clin. J. Med. 2000; 67(10): 739, 743-6, 749-754.Weiss D. How to help your patients lose weight: current therapy for obesity // Cleve. Clin. J. Med. 2000; 67(10): 739, 743-6, 749-754.

The authors declare that there are no conflicts of interest present.